These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 18280438

  • 1. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
    Brooks B, Delaney-Robinson C, Molyneaux L, Yue DK.
    J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.
    PKC-DRS2 GroupBeetham Eye Institute, Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215, USA. LPAiello@Joslin.Harvard.edu, Aiello LP, Davis MD, Girach A, Kles KA, Milton RC, Sheetz MJ, Vignati L, Zhi XE.
    Ophthalmology; 2006 Dec; 113(12):2221-30. PubMed ID: 16989901
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.
    Ekberg K, Brismar T, Johansson BL, Lindström P, Juntti-Berggren L, Norrby A, Berne C, Arnqvist HJ, Bolinder J, Wahren J.
    Diabetes Care; 2007 Jan; 30(1):71-6. PubMed ID: 17192336
    [Abstract] [Full Text] [Related]

  • 14. The effects of diabetes and aminoguanidine treatment on endothelial function in a primate model of type 1 diabetes.
    Brooks BA, Heffernan S, Thomson S, McLennan SV, Twigg SM, Yue DK.
    Am J Primatol; 2008 Aug; 70(8):796-802. PubMed ID: 18481256
    [Abstract] [Full Text] [Related]

  • 15. NO-dependent smooth muscle vasodilatation is reduced in NIDDM patients with peripheral sensory neuropathy.
    Pitei DL, Watkins PJ, Edmonds ME.
    Diabet Med; 1997 Apr; 14(4):284-90. PubMed ID: 9113481
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relationship between peripheral diabetic neuropathy and microvascular reactivity in patients with type 1 and type 2 diabetes mellitus -- neuropathy and microcirculation in diabetes.
    Kasalová Z, Prázný M, Skrha J.
    Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):52-7. PubMed ID: 16570233
    [Abstract] [Full Text] [Related]

  • 18. 3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes.
    Vehkavaara S, Yki-Järvinen H.
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):325-30. PubMed ID: 14684428
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes.
    Brooks BA, Franjic B, Ban CR, Swaraj K, Yue DK, Celermajer DS, Twigg SM.
    Diabetes Obes Metab; 2008 Sep; 10(9):739-46. PubMed ID: 17941867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.